TickerFiles

Barinthus Biotherapeutics plc. 10-Q filing

Filed 2025-08-07 · Report date 2025-06-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001828185-25-000059
Form type
10-Q
CIK
0001828185
Primary document
https://www.sec.gov/Archives/edgar/data/1828185/000182818525000059/brns-20250630.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Barinthus Biotherapeutics plc..

Reported financial metrics

MetricCurrentPriorChange
Operating Income$-43.9M--
Net Income$-40.8M--
Eps Basic-1.01--
Eps Diluted-1.01--
Cash And Equivalents$86.3M--
Total Assets$129.6M--
Total Liabilities$27.1M--
Shareholders Equity$102.4M--
Operating Cash Flow$-33.0M--
Capital Expenditures$37,000--